日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CD300ld blockade overcomes PMN-MDSC-mediated vaccine resistance in advanced tumors

CD300ld阻断可克服晚期肿瘤中PMN-MDSC介导的疫苗耐药性

Wang, Xianglei; Xue, Shiyao; Li, Yuwei; Yang, Miaomiao; Yu, Haotian; Wang, Mengyan; Li, Suxin; Lu, Zhigang; Luo, Min

CD30 as a Target Molecule in the Diagnosis and Therapy of Lymphomas

CD30作为淋巴瘤诊断和治疗的靶分子

Stein, Harald; Falini, Brunangelo

CD30 CAR-T cells in combination with anti-PD-1 camrelizumab in relapsed/refractory CD30(+) lymphomas

CD30 CAR-T细胞联合抗PD-1卡瑞利珠单抗治疗复发/难治性CD30(+)淋巴瘤

Yu, Min; Liu, Longzi; Zhou, Xiaoxi; Zhou, Yulan; Xu, Shan; Kong, Fancong; Qi, Ling; Wu, Jing; Zhang, Tongcun; Li, Fei

Research note: Marek's disease oncogene Meq directly regulates CD30 high expression through binding to two regions in promoter

研究简报:马立克氏病癌基因Meq通过与启动子中的两个区域结合,直接调控CD30的高表达

Du, Yushuang; Zheng, Gang; Yang, Yuqin; Zhang, Jiannan; Li, Juan; Lian, Ling

Put the CAR-T before the HRS: Advances in Anti-CD30 Immunotherapy Targeting Hodgkin/Reed-Sternberg Cells in Classical Hodgkin Lymphoma

先进行 CAR-T 疗法,再进行 HRS 疗法:靶向经典霍奇金淋巴瘤中霍奇金/里德-斯滕伯格细胞的抗 CD30 免疫疗法的进展

Mayasin, Yuriy; Osinnikova, Maria; Osadchaya, Daria; Dmitrienko, Victoria; Gorodilova, Anna; Kharisova, Chulpan; Kitaeva, Kristina; Solovyeva, Valeria; Rizvanov, Albert

Brentuximab vedotin and radiotherapy for CD30-positive cutaneous T-cell lymphoma - a retrospective multicenter analysis

布伦妥昔单抗联合放射疗法治疗CD30阳性皮肤T细胞淋巴瘤——一项回顾性多中心分析

Schummer, Patrick; Glatzel, Caroline; Schrüfer, Philipp; Lawrenz, Ingulf; Dobos, Gabor; Wehkamp, Ulrike; Hüning, Svea; Stranzenbach, René; Nicolay, Jan P; Goebeler, Matthias; Wobser, Marion

A CD30-positive variant of intravascular large B-cell lymphoma presenting as diffuse interstitial lung disease and generalized lymphadenopathy: a case report

CD30阳性血管内大B细胞淋巴瘤变异型表现为弥漫性间质性肺病和全身淋巴结肿大:病例报告

Wang, Lei; Cai, Yongdeng; Wang, Mengyao; Gao, Cui; Zhu, Jianni; Xue, Guangwei; Dong, Zheng; Ge, Changsheng; Zhang, Wei; Li, Zongfang; Liu, Zongtao; Chen, Yunqing; Du, Cailing; Li, Changjiang; Liang, Yajing; Wang, Lu; Mi, Baomei

CD300C reduces lung adenocarcinoma susceptibility through regulation of CD62L⁻ monocytes: a Mendelian randomization study

CD300C通过调节CD62L⁻单核细胞降低肺腺癌易感性:一项孟德尔随机化研究

Chen, Huiling; Xue, Zhichun; Huang, Liwen; Zeng, Ying; Tang, Meiyan; Han, Kunhuang; Chen, Jia; Deng, Xinyu; Fang, Guiju

CD30 knockout attenuates experimental colitis by reducing inflammatory cytokine production

CD30基因敲除通过减少炎症细胞因子的产生来减轻实验性结肠炎。

Guo, Lili; He, Zhaocai; Yang, Changqing; Chen, Xiaorong; Wang, Juan

Synergistic adverse prognostic impact of CD30 and Epstein-Barr virus in peripheral T-cell lymphoma: CD30 identifies a high-risk subgroup in Epstein-Barr virus-encoded RNA -positive patients

CD30 和 Epstein-Barr 病毒在周围 T 细胞淋巴瘤中具有协同不良预后作用:CD30 可识别 Epstein-Barr 病毒编码 RNA 阳性患者的高危亚组

Chen, Ze-Tao; Huang, Ling; Zhang, Xiao-Dan; Wang, Ning; Jiang, Xin-Miao; Wei, Xiao-Juan; Zhang, Hong; Guo, Han-Guo; Lin, Cai-Di; Chen, Fei-Li; Liu, Si-Chu; Liang, Zhan-Li; Li, Wen-Yu